A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy

New York Presbyterian Hospital, New York

New York Medical College, Valhalla

Local Institution, Buffalo

Local Institution, Pittsburgh

Local Institution, Baltimore

Local Institution, Durham

Santee Hematology/Oncology, Sumter

Local Institution, Jacksonville

Local Institution, Jacksonville

M.D. Anderson Cancer Center Orlando, Orlando

Local Institution, Pembroke Pines

Dr. Marshall Schreeder, Huntsville

Local Institution, Hazard

Local Institution, Cleveland

Local Institution, Indianapolis

Local Institution, Ann Arbor

Local Institution, Rochester

Local Institution, Chicago

Local Institution, St Louis

Local Institution, Kansas City

Local Institution, Omaha

Local Institution, Little Rock

Local Institution, Oklahoma City

Local Institution, Tulsa

Local Institution, Dallas

Local Institution, Houston

Local Institution, Aurora

Local Institution, Las Vegas

Local Institution, Los Angeles

Local Institution, Los Angeles

Local Institution, Los Angeles

Local Institution, Beverly Hills

Local Institution, Redondo Beach

Local Institution, Long Beach

Local Institution, Northridge

Local Institution, La Verne

Local Institution, Alhambra

Local Institution, La Jolla

Local Institution, Anaheim

Local Institution, Fullerton

Local Institution, Oxnard

Local Institution, Santa Maria

Local Institution, San Francisco

Local Institution, Stanford

Local Institution, Hackensack